Radical resection
Sponsors
Simcere Pharmaceutical Co., Ltd, Peking Union Medical College Hospital, xuexin he, Fudan University, Peking University Cancer Hospital & Institute
Conditions
Breast CancerEGFR Positive Non-small Cell Lung CancerEarly Stage Hepatocellular CarcinomaNSCLCNeoadjuvant ChemoradiationNeoadjuvant TherapyNon-small Cell Lung CancerOligometastasis
Phase 2
The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma
NCT01055743
Start: 2009-08-31End: 2014-08-31Target: 250Updated: 2010-01-26
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
RecruitingNCT07622706
Start: 2026-09-03End: 2029-12-30Target: 60Updated: 2026-10-27
Phase 3
Unknown Phase
Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.
NCT03042000
Start: 2017-02-28End: 2021-12-31Target: 1200Updated: 2017-02-03
Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis
RecruitingNCT04158843
Start: 2020-05-09End: 2026-12-31Target: 183Updated: 2020-05-12
Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer
RecruitingNCT06349252
Start: 2021-01-01End: 2025-01-01Target: 1263Updated: 2024-04-05